Journal of Cellular and Molecular Medicine

Papers
(The H4-Index of Journal of Cellular and Molecular Medicine is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Issue Information131
Issue Information104
Integrated network pharmacology to investigate the mechanism of Salvia miltiorrhiza Bunge in the treatment of myocardial infarction80
Corrigendum79
Correction to RDM1 promotes critical processes in breast cancer tumorigenesis77
WKYMVm ameliorates obesity by improving lipid metabolism and leptin signalling75
Up‐regulation ofPRKDCwas associated with poor renal dysfunction after renal transplantation: A multi‐centre analysis72
GABRD Accelerates Tumour Progression via Regulating CCND1 Signalling Pathway in Gastric Cancer69
62
MRPS16 promotes lung adenocarcinoma growth via the PI3K/AKT/Frataxin signalling axis60
Apocynin exerts cytoprotective effects on dexamethasone‐induced osteoblasts by inhibiting oxidative stress through the Nrf2 signalling pathway60
ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT/β‐catenin/HK2 axis58
Discovery of Endothelial–Monocyte Crosstalk in Ischemic‐Reperfusion Injury Following Liver Transplantation Based on Integration of Single‐Cell RNA and Transcriptome RNA Sequencing56
The Hippo signalling pathway and its impact on eye diseases55
Antitumor effect and metabonomics of niclosamide micelles55
KRAS mutation promotes the colonization of Fusobacterium nucleatum in colorectal cancer by down‐regulating SERTAD453
PSMC4 promotes prostate carcinoma progression by regulating the CBX3EGFR‐PI3K‐AKT‐mTOR pathway53
FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway52
Baicalin alleviates angiotensin II‐induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway51
Identification of optimal reference genes for gene expression studies in a focal cerebral ischaemia model—Spatiotemporal effects49
MARCH5 Promotes Cardiac Hypertrophy by Regulating Akt/mTOR/Gsk‐3β/GATA4 Signalling Pathway47
Tamarixetin Suppresses Colorectal Cancer Progression by Targeting DPP7‐Mediated WNT3A/β‐Catenin Signalling Pathway46
A novel KCND3 variant in the N‐terminus impairs the ionic current of Kv4.3 and is associated with SCA19/2246
Puerarin Protects Myocardium From Ischaemia/Reperfusion Injury by Inhibiting Ferroptosis Through Downregulation of VDAC145
Neuroprotective effects on microglia and insights into the structure–activity relationship of an antioxidant peptide isolated from Pelophylax perezi45
Potential Role of High‐Intensity Interval Training‐Induced Increase in Humanin Levels for the Management of Type 2 Diabetes44
D‐Chiro‐Inositol and LPS Induce a PCOS‐Like Hyperandrogenic Response in Human KGN Granulosa Cells44
Ephedrine Attenuates LPS‐Induced Acute Lung Injury in Mice by Inhibiting OTUB1 and Promoting K48 Ubiquitination of HIF1α43
Differential Expression Patterns of SLCO Solute Carriers in Human Breast Cancer Cell Lines and Tumour Samples43
ANS‐SCMC: A matrix completion method based on adaptive neighbourhood similarity and sparse constraints for predicting microbe‐disease associations42
Advancing lung adenocarcinoma prognosis and immunotherapy prediction with a multi‐omics consensus machine learning approach42
Unveiling the Role of PNMA2 in Endometriosis: From Proliferation and Apoptosis to Immunomodulation41
Design of multi‐epitope chimeric vaccine against Monkeypox virus and SARS‐CoV‐2: A vaccinomics perspective40
Exploring the immune escape mechanisms in gastric cancer patients based on the deep AI algorithms and single‐cell sequencing analysis40
Genetic interactions and pleiotropy in metabolic diseases: Insights from a comprehensive GWAS analysis39
Study of the mechanism by which Xiaoyan decoction combined with E7449 regulates tumorigenesis in lung adenocarcinoma37
EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy37
0.097764015197754